Evolva Holding SA represents core values of innovation, sustainability, and collaboration. As a biotech company, Evolva is driven by a strong commitment to creating sustainable and environmentally friendly solutions for various industries. With a focus on biosynthesis and fermentation, the company aims to revolutionize the production of ingredients, compounds, and molecules. Evolva's corporate philosophy revolves around utilizing cutting-edge technology, fostering partnerships, and delivering value to customers and stakeholders. By continually pushing the boundaries of science and embracing a collaborative approach, Evolva strives to make a positive and lasting impact in sectors such as flavors and fragrances, health and wellness, and agriculture.

Evolva Holding SA is primarily present in various countries and regions worldwide. Some notable locations where the company operates include Switzerland, the United States, Germany, and France. Additionally, Evolva has a strong presence in other European countries, as well as in parts of Asia and South America. With its global reach, Evolva Holding SA continues to expand its market presence and collaborate with partners across different regions to deliver innovative solutions and drive growth in the field of sustainable ingredients.

Some significant milestones achieved by Evolva Holding SA include the successful commercialization of its innovative ingredients and products, such as its flagship ingredient nootkatone, a natural insect repellent. The company has also made advancements in its fermentation and biotechnology platforms, leading to the development of novel high-value ingredients for various industries. Furthermore, Evolva has established collaborations and partnerships with major players in the food, beverage, and personal care sectors. These milestones demonstrate Evolva Holding SA's commitment to research, development, and commercialization, positioning the company as a leader in sustainable and science-driven solutions.

Evolva Holding SA is a Swiss biotechnology company that specializes in the development and commercialization of innovative products for the healthcare, nutrition, and personal care sectors. Established in 2004, Evolva focuses on transforming nature's building blocks into high-value, sustainable ingredients using its proprietary technology platform. With a strong emphasis on research and development, the company has successfully created a portfolio of bio-based products, including specialty ingredients and natural compounds. Evolva's commitment to innovation and sustainability has garnered recognition across various industries, positioning the company as a trusted leader in biotechnology.

The main competitors of Evolva Holding SA in the market include companies like Ginkgo Bioworks, Amyris, and Intrexon. These companies operate in the field of biotechnology and specialize in the development and production of sustainable and natural ingredients. They, like Evolva Holding SA, contribute to the advancement of innovative and environmentally friendly solutions in various industries such as food, nutrition, and personal care. Through continuous research and development efforts, Evolva Holding SA strives to establish a strong competitive edge in the market and maintain a leading position among its industry counterparts.

Evolva Holding SA is primarily active in the industries of specialty ingredients and biomaterials.

The business model of Evolva Holding SA is centered around the production and commercialization of high-performance, sustainable ingredients for various industries. By leveraging its proprietary biotechnology platform, the company focuses on the development of innovative, nature-inspired products that can be used in sectors such as flavor and fragrance, nutrition, and personal care. Evolva's business model relies on partnerships and collaborations with industry leaders to bring these ingredients to market. Through continuous research and development, Evolva aims to deliver solutions that address global challenges while meeting the demand for sustainable, high-quality products. Evolva Holding SA is committed to revolutionizing ingredient production and contributing to a more sustainable future.

De Evolva Holding K/W is -0,37.

De Evolva Holding KUV is 0,17.

De AlleAktien Kwaliteitsscore voor Evolva Holding is 4/10.

De verwachte Evolva Holding omzet is 26,87 mln. CHF.

De verwachte Evolva Holding winst is -12,01 mln. CHF.

The Evolva Holding SA is a company specialized in the development of specific active ingredients and additives for food and nutraceuticals. The company's business model is based on three sectors: food, health, and cosmetics. In the food sector, Evolva provides innovative solutions for food and beverage manufacturers, offering natural additives as substitutes for artificial flavorings and preservatives. In the health sector, Evolva develops known and novel active ingredients for nutraceuticals, including non-addictive analgesics such as GLPG2737. In the cosmetics sector, Evolva focuses on the production of natural ingredients, offering biotechnologically produced active substances with high efficacy and compatibility. The company collaborates closely with other companies to successfully market its products, licensing its technology platforms to generate new active ingredients and applications. Evolva's business model is characterized by a strong focus on research and development and cooperation with partners, aiming to increase the benefits of biotechnology for society and achieve long-term profitability.

Evolva Holding keert een dividend van 0 CHF uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Evolva Holding of het bedrijf keert geen dividend uit.

De ISIN van Evolva Holding is CH0021218067.

Het WKN van Evolva Holding is A0EAKH.

De ticker van Evolva Holding is EVE.SW.

Binnen de laatste 12 maanden betaalde Evolva Holding een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal Evolva Holding naar verwachting een dividend van 0 CHF betalen.

De dividendrendement van Evolva Holding is momenteel .

Evolva Holding betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

Evolva Holding betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 CHF verwacht. Dit komt overeen met een dividendrendement van 0 %.

Evolva Holding wordt toegewezen aan de sector 'Grondstoffen'.

Om het laatste dividend van Evolva Holding van 17-12-2024 ter hoogte van 0 CHF te ontvangen, moest je het aandeel voor de ex-datum op 17-12-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 17-12-2024.

In het jaar 2023 heeft Evolva Holding 0 CHF aan dividenden uitgekeerd.

De dividenden van Evolva Holding worden in CHF uitgekeerd.